Evidence map›Paper›PMID 36770665›Full record

ArticleMolecules (Basel, Switzerland)2023

Inhibition of Skin Pathogenic Bacteria, Antioxidant and Anti-Inflammatory Activity of Royal Jelly from Northern Thailand.

Vitchayaporn Uthaibutra, Thida Kaewkod, Pichet Prapawilai, Hataichanok Pandith, Yingmanee Tragoolpua

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Royal Jelly: Biological Action and Health Benefits.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Vitchayaporn UthaibutraDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
Thida KaewkodDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
Pichet PrapawilaiDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
Hataichanok PandithDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
Yingmanee TragoolpuaDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-0754-0638
Chiang Mai University · TH

Funding

National Research Council of Thailand NRCT5-RRI63004-M09
6 · The paper itself

Abstract

Royal jelly is a nutritious substance produced by the hypopharyngeal and mandibular glands of honeybees. Royal jelly possesses many attractive and beneficial properties which make it an ideal component in medical and pharmaceutical products. The antibacterial, antioxidant, and anti-inflammatory activities of royal jelly from honeybees (

Indexed as

AntioxidantsMethicillin-Resistant Staphylococcus aureusAnimalsAnti-Bacterial AgentsAnti-Inflammatory AgentsBeesCell LineFatty AcidsMiceRoyal JellySkinStaphylococcus aureusThailandAnti-Bacterial AgentsAnti-Inflammatory AgentsAntioxidantsFatty AcidsRoyal Jellyantibacterial activityanti-inflammatoryantioxidant activityroyal jellyskin pathogenic bacteria

Identifiers

PMID36770665
PMCPMC9920569
OpenAlexW4317517574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.